A

Aclaris Therapeutics, Inc.ACRS

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D.

US StocksHealthcareSmall CapBiotechnology

ACRS Price Trend

Aclaris Therapeutics, Inc. · Full TradingView Chart

NASDAQ:ACRS

Onchain Activity